What is Graft Versus Host Disease

Graft Versus Host Disease (GVHD) is a serious medical complication where donor immune cells from a stem cell or bone marrow transplant recognize the recipient's body as "foreign" and begin to attack healthy tissues. It is classified into two main types, acute and chronic, based on the timing of symptom onset and the specific organs involved.

What causes Graft Versus Host Disease?

The underlying mechanism of Graft Versus Host Disease involves donor T-lymphocytes (white blood cells) identifying the patient's cells as non-self. This triggers an inflammatory immune response that damages host organs. Unlike organ rejection, where the patient's body attacks the donor organ, Graft Versus Host Disease is a unique process where the transplanted immune system actively attacks the patient.

How is Graft Versus Host Disease classified?

Clinicians typically categorize Graft Versus Host Disease based on the timeline of presentation:

• Acute GVHD: Usually occurs within the first 100 days post-transplant, primarily affecting the skin, liver, and gastrointestinal tract.


• Chronic GVHD: Typically appears more than 100 days after the procedure and can affect almost any organ system, often resembling autoimmune disorders like scleroderma or Sjögren’s syndrome.

Who is at risk for Graft Versus Host Disease?

Graft Versus Host Disease occurs exclusively in patients who have undergone an allogeneic hematopoietic stem cell transplant. Incidence rates vary significantly depending on the donor match and the patient's age; generally, 30% to 50% of patients who receive a transplant from a matched unrelated donor will develop some form of Graft Versus Host Disease. It affects both genders equally, and there is no specific geographic predisposition, as the risk is tied to the transplant procedure itself rather than environmental factors.

How does the DiseaseMaps community support patients?

Living with Graft Versus Host Disease can be isolating due to its complex, multi-system nature. At DiseaseMaps.org, 50 members have joined our community to share their personal experiences, symptom management strategies, and emotional support, helping others navigate the challenges of life after a transplant.

Next steps

• Consult your transplant hematologist or oncologist immediately if you notice new rashes, jaundice, or digestive changes.


• Keep a detailed symptom journal to share with your medical team during follow-up appointments.


• Connect with the 50 members on DiseaseMaps.org to share experiences and coping mechanisms.


• Ask your specialist about clinical trials regarding new immunosuppressive therapies for refractory cases.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• National Institutes of Health (NIH) GARD: Graft Versus Host Disease Overview


• Orphanet: Rare Disease Database (ORPHA: 388)


• Blood & Marrow Transplant Information Network (BMT InfoNet)


• National Marrow Donor Program (Be The Match)